SB

Singapore Bio-Innovations

Asia, Central Region, Singapore, Singapore

Description

Singapore Bio-Innovations is a venture capital firm that finances later stage investments.

Investor Profile

Singapore Bio-Innovations has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (67%)
  • Series Unknown (17%)
  • Series B (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Developer Platform
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Singapore Bio-Innovations frequently co-invest with?

Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 4
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 4
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 4
Alloy Ventures
North America, California, United States, Palo Alto
Co-Investments: 4
LB
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 3
GBS Ventures
Oceania, Victoria, Australia, Melbourne
Co-Investments: 4
Advanced Technology Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Diamond Capital Company
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1

What are some of recent deals done by Singapore Bio-Innovations?

Humanigen

Burlingame, California, United States

Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series DDec 22, 2008
Amount Raised: $12,000,000
Kalobios Pharmaceuticals, Inc.

South San Francisco, California, United States

KaloBios Pharmaceuticals is a biotechnology company that develops advancing medicines for patients.

Biotechnology
Series DSep 23, 2008
Amount Raised: $20,000,000
Humanigen

Burlingame, California, United States

Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series DSep 23, 2008
Amount Raised: $20,000,000
Humanigen

Burlingame, California, United States

Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series BMar 16, 2005
Amount Raised: $20,000,000
Five Prime Therapeutics

San Francisco, California, United States

FivePrime is a clinical-stage biotechnology company that develops treatments for cancers.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownFeb 8, 2005
Amount Raised: $45,000,000
Aderis Pharmaceuticals

Richmond, Virginia, United States

Aderis Pharmaceuticals focused on discovery, development and commercialization of products for the diagnosis.

BiopharmaBiotechnologyDeveloper PlatformHealth Diagnostics
Series DOct 9, 2001
Amount Raised: $45,000,000